Skip to main content
. 2020 Jan 21;12(2):1322–1331. doi: 10.18632/aging.102685

Table 4. Association between ANAs and IAS burden among different ages.

Age Single IAS vs No IAS IAS ≥2 vs No IAS
OR (95% CI) P value OR (95% CI) P value
ANAs (+) vs ANAs (-) Age≤60 (n=485) Crude OR 3.531(2.091, 5.961) <0.001 3.852(1.967, 7.540) <0.001
Adjusted OR1 4.027 (2.308, 7.026) <0.001 4.536(2.104,9.781) <0.001
Adjusted OR2 3.855 (1.625, 9.144) 0.002 5.655(1.574,20.324) 0.008
60<Age≤75 (n=1173) Crude OR 1.085(0.776,1.516) 0.634 3.074(2.187, 4.320) <0.001
Adjusted OR1 1.217(0.858,1.725) 0.271 4.163(2.822, 6.142) <0.001
Adjusted OR2 1.038(0.660,1.631) 0.872 4.393 (2.674,7.216) <0.001
Age>75 (n=834) Crude OR 1.221(0.801,1.862) 0.354 2.491(1.699,3.651) <0.001
Adjusted OR1 1.238(0.802,1.911) 0.336 3.034 (2.004,4.592) <0.001
Adjusted OR2 0.831 (0.445,1.550) 0.560 4.083 (2.245, 7.423) <0.001

IAS, Intracranial arterial stenosis; ANAs, antinuclear antibodies; OR, odds ratio; CI, confidence interval; Adjusted OR1, adjusted for age, gender, MAP, stroke history, hypertension, diabetes mellitus, coronary heart disease, atrial fibrillation, hyperuricemia, smoking habits and drinking habits; Adjusted OR2, adjusted for the items in OR1 plus blood glucose, serum uric acid, serum homocysteine, serum triglyceride, serum cholesterol, serum high density lipoprotein, serum low density lipoprotein, neutrophil and lymphocyte counts.